HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Youngji Han Selected Research

psicose (D-psicose)

1/2022Allulose Attenuated Age-Associated Sarcopenia via Regulating IGF-1 and Myostatin in Aged Mice.
8/2020d-allulose Ameliorates Metabolic Dysfunction in C57BL/KsJ-db/db Mice.
7/2020Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of mRNA Expression and Alteration of the Microbiome Composition.
1/2020Alteration of Microbiome Profile by D-Allulose in Amelioration of High-Fat-Diet-Induced Obesity in Mice.
1/2020Tracing the Anti-Inflammatory Mechanism/Triggers of d-Allulose: A Profile Study of Microbiome Composition and mRNA Expression in Diet-Induced Obese Mice.
12/2018Gastrointestinal Tolerance of D-Allulose in Healthy and Young Adults. A Non-Randomized Controlled Trial.
1/2018A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
1/2016d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Youngji Han Research Topics

Disease

7Obesity
05/2022 - 01/2016
5Inflammation (Inflammations)
05/2022 - 02/2016
4Body Weight (Weight, Body)
08/2021 - 01/2016
2Sarcopenia
04/2022 - 01/2022
2Hyperinsulinism (Hyperinsulinemia)
08/2020 - 11/2019
2Dyslipidemias (Dyslipidemia)
07/2020 - 11/2019
2Insulin Resistance
07/2020 - 11/2019
2Overweight
01/2018 - 02/2016
1Fibrosis (Cirrhosis)
04/2022
1Hyperglycemia
08/2020
1Type 2 Diabetes Mellitus (MODY)
07/2020
1Weight Gain
01/2020
1Nausea
12/2018
1Anorexia
12/2018
1Abdominal Pain (Pain, Abdominal)
12/2018
1Headache (Headaches)
12/2018
1Diarrhea
12/2018

Drug/Important Bio-Agent (IBA)

8psicose (D-psicose)IBA
01/2022 - 01/2016
6LipidsIBA
08/2021 - 01/2016
4Glucose (Dextrose)FDA LinkGeneric
05/2022 - 01/2016
3EnzymesIBA
07/2020 - 01/2016
3LeptinIBA
01/2020 - 01/2016
3ResistinIBA
01/2020 - 01/2016
2CollagenIBA
05/2022 - 04/2022
2Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2022
2Messenger RNA (mRNA)IBA
01/2022 - 07/2020
2AntioxidantsIBA
01/2022 - 02/2016
2Sweetening Agents (Sweeteners)IBA
01/2020 - 01/2016
2SugarsIBA
12/2018 - 01/2018
1Cytidine Triphosphate (CTP)IBA
04/2022
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2022
1MyostatinIBA
01/2022
1Blood Glucose (Blood Sugar)IBA
07/2020
116S Ribosomal RNAIBA
01/2020
1myricitrinIBA
11/2019
1ChitosanIBA
09/2018
1Ethanol (Ethyl Alcohol)IBA
02/2016
1FructoseIBA
01/2016

Therapy/Procedure

1Traditional Medicine (Folk Remedies)
05/2022